428 Genomic instability metric concordance between oncoscan™, cytosnp and an fda-approved HRD test
Răzvan Cristescu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Matthew J. Marton(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gladys Arreaza(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ping Qiu(Huzhou Women and Children's Hospital), Andrew Albright(Merck & Co., Inc., Rahway, NJ, USA (United States)), Chen Cai(University of Science and Technology of China), Xiao Qiao Liu(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 4
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
A methanotrophic archaeon couples anaerobic oxidation of methane to Fe(III) reduction
|The ISME Journal|2018|428
Anaerobic methane oxidation coupled to manganese reduction by members of the <i>Methanoperedenaceae</i>
|The ISME Journal|2020|347